Clinical Trials Directory

Trials / Completed

CompletedNCT03677297

"Efficacy Of 1.2% Rosuvastatin Gel In The Management Of Infrabony Defects"

Comparative Evaluation of Treatment Of Infrabony Defects With and Without 1.2% Rosuvastatin Gel: In-Vivo Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Dr. D. Y. Patil Dental College & Hospital · Academic / Other
Sex
All
Age
30 Years – 50 Years
Healthy volunteers
Accepted

Summary

Study aims to evaluate clinical and radiographic effectiveness of 1.2% Rosuvastatin gel in the treatment of Infrabony defects in chronic periodontitis patients.

Detailed description

Source from where the patients will be selected: 10 patients with chronic periodontitis having two or more infrabony defects will be selected from the Outpatient section of Dept. of Periodontology, Dr. D. Y. Patil Dental College and Hospital, Pimpri, Pune - 18. A detailed clinical examination, case history and written consent will be obtained from all the participants. Before surgery, each patient will be given careful instructions regarding proper oral hygiene measures. A full-mouth phase I therapy will be performed. A periodontal re-evaluation will be performed after 4 to 6 weeks of phase 1 therapy to confirm the desired sites for the study. The selected sites will be divided randomly by using a Sequentially numbered, opaque, sealed envelopes (SNOSE) randomization into control and test sites. The control site will be treated with Access Flap Surgery (AFS), whereas test sites will be treated with AFS and 1.2% Rosuvastatin gel. Suitable antibiotics and analgesics will be prescribed along with Chlorhexidine digluconate rinses (0.2%) twice daily for 14 days. Patients will be examined at 4 weeks, 3 and 6 month after surgery.

Conditions

Interventions

TypeNameDescription
DRUGRosuvastatinTest sites were treated with access flap surgery and 1.2% Rosuvastatin gel

Timeline

Start date
2016-01-28
Primary completion
2017-08-01
Completion
2017-11-10
First posted
2018-09-19
Last updated
2018-09-19

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT03677297. Inclusion in this directory is not an endorsement.